Title: Walker Anderson Long: Innovator in Injectable Meclizine Formulations
Introduction
Walker Anderson Long is an inventive mind based in the United States. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable formulations for treating conditions such as vertigo, nausea, and vomiting. His innovative approach aims to enhance the effectiveness of meclizine, a common medication used for these ailments.
Latest Patents
Walker Anderson Long is credited with the patent titled "Injectable Meclizine Formulations And Methods." This patent outlines methods for treating or preventing vertigo, nausea, or vomiting by injecting a subject with a formulation that includes meclizine or its pharmaceutically acceptable salts, along with a chemically modified cyclodextrin and an aqueous carrier medium. The formulation is designed to have a pH between about 2 and about 7, ensuring optimal stability and efficacy.
Career Highlights
Walker is currently associated with Genebiology, Inc., where he continues to work on innovative pharmaceutical solutions. His focus on injectable formulations demonstrates his commitment to improving patient care through advanced medical technologies. Despite having no patents to his name prior to his recent work, his contributions are poised to make a significant impact in the pharmaceutical industry.
Collaborations
Walker collaborates with Edwin Curran Murphy, a fellow innovator in the field. Their partnership is expected to yield further advancements in pharmaceutical formulations and treatments.
Conclusion
Walker Anderson Long is a promising inventor whose work in injectable meclizine formulations showcases his dedication to enhancing medical treatments. His innovative spirit and collaboration with industry professionals position him as a key player in the pharmaceutical landscape.